EBF

Add Bookmark

 - 
  • EVENTS

21.11. - 23.11.2018
Barcelona, Spain
http://bcn.europeanbioanalysisforum.eu/

Ground floor / C3

Shimadzu is one of the worldwide leading manufacturers of analytical instrumentation. Its equipment and systems are used as essential tools in all areas including Pharma, Biopharma and clinical research. Since more than 140 years, Shimadzu is at the service of science ensuring precise and reliable analyses. Among the leaders in Mass Spectrometry, Shimadzu is offering a full range of LC-MS/MS systems to fit all needs depending on the application, and will exhibit disruptive technologies and solutions like Q-TOF LCMS-9030, nSMOL for simple and precise quantitation of mAB and microsampling. In addition, we will present ALSACHIM portfolio of highly stable isotope labelled compounds as well as customized solutions for the Pharma industry. Take the opportunity to visit our booth C3.

Oral Presentation

Thursday, 22 November 2017
17:20 - 17:40 h

Validated bioanalysis for therapeutic antibodies by LC-MS: Fab-selective proteolysis nSMOL 
Presenter: Takashi Shimada, Shimadzu

Product Lineup

  • LCMS-9030: “A Q-TOF of Shimadzu’s engineering DNA! ”
    Ultra-fast acquisition rates and core ion beam technologies
    • Ultra-fast (UF) acquisition rates and core ion beam technologies developed for the triple quadrupole platform has opened-up new possibilities in quantitative mass spectrometry.
    • The new LCMS-9030 Q-TOF builds on this proven platform by rethinking time-of-flight detection.
    • In the LCMS-9030, core ion beam technologies transition towards a unique approach in ion gating using UFaccumulation to create a precise pulse of ions into the flight tube.
  • MSW² Microsampling tool to collect volumetric samples of plasma
    The MSW² (RUO) is a unique microsampling tool to collect volumetric samples of plasma from reduced whole blood volume (23µl) on small animals.
  • nSMOL nano-surface and molecular orientation limited proteolysis  
    An unparalleled convenient and rapid workflow provided by the nSMOL Antibody BA Kit to dramatically improve the productivity and robustness of LCMS mAb bioanalysis.